Transglutaminase 2 Promotes Autophagy by LC3 Induction through p53 Depletion in Cancer Cell |
Kang, Joon Hee
(Tumor Microenvironment Research Branch, Division of Cancer Biology, Research Institute, National Cancer Center)
Lee, Seon-Hyeong (Tumor Microenvironment Research Branch, Division of Cancer Biology, Research Institute, National Cancer Center) Cheong, Heesun (Tumor Microenvironment Research Branch, Division of Cancer Biology, Research Institute, National Cancer Center) Lee, Chang Hoon (College of Pharmacy, Dongguk University) Kim, Soo-Youl (Tumor Microenvironment Research Branch, Division of Cancer Biology, Research Institute, National Cancer Center) |
1 | Birgisdottir, A. B., Lamark, T. and Johansen, T. (2013) The LIR motif - crucial for selective autophagy. J. Cell Sci. 126, 3237-3247. DOI |
2 | Cao, J. and Huang, W. (2016) Compensatory increase of transglutaminase 2 is responsible for resistance to mTOR inhibitor treatment. PLoS ONE 11, e0149388. DOI |
3 | Cao, L., Petrusca, D. N., Satpathy, M., Nakshatri, H., Petrache, I. and Matei, D. (2008) Tissue transglutaminase protects epithelial ovarian cancer cells from cisplatin-induced apoptosis by promoting cell survival signaling. Carcinogenesis 29, 1893-1900. DOI |
4 | Cheong, H., Lindsten, T. and Thompson, C. B. (2012a) Autophagy and ammonia. Autophagy 8, 122-123. DOI |
5 | Cheong, H., Lu, C., Lindsten, T. and Thompson, C. B. (2012b) Therapeutic targets in cancer cell metabolism and autophagy. Nat. Biotechnol. 30, 671-678. DOI |
6 | D'Eletto, M., Farrace, M. G., Falasca, L., Reali, V., Oliverio, S., Melino, G., Griffin, M., Fimia, G. M. and Piacentini, M. (2009) Transglutaminase 2 is involved in autophagosome maturation. Autophagy 5, 1145-1154. DOI |
7 | D'Eletto, M., Farrace, M. G., Rossin, F., Strappazzon, F., Giacomo, G. D., Cecconi, F., Melino, G., Sepe, S., Moreno, S., Fimia, G. M., Falasca, L., Nardacci, R. and Piacentini, M. (2012) Type 2 transglutaminase is involved in the autophagy-dependent clearance of ubiquitinated proteins. Cell Death Differ. 19, 1228-1238. DOI |
8 | Folk, J. E. (1980) Transglutaminases. Annu. Rev. Biochem. 49, 517-531. DOI |
9 | Kang, J. H., Lee, J. S., Hong, D., Lee, S. H., Kim, N., Lee, W. K., Sung, T. W., Gong, Y. D. and Kim, S. Y. (2016) Renal cell carcinoma escapes death by p53 depletion through transglutaminase 2-chaperoned autophagy. Cell Death Dis. 7, e2163. DOI |
10 | Kang, S. K., Lee, J. Y., Chung, T. W. and Kim, C. H. (2004) Over-expression of transglutaminase 2 accelerates the erythroid differentiation of human chronic myelogenous leukemia K562 cell line through PI3K/Akt signaling pathway. FEBS Lett. 577, 361-366. DOI |
11 | Kim, D. S., Choi, Y. B., Han, B. G., Park, S. Y., Jeon, Y., Kim, D. H., Ahn, E. R., Shin, J. E., Lee, B. I., Lee, H., Hong, K. M. and Kim, S. Y. (2011) Cancer cells promote survival through depletion of the von Hippel-Lindau tumor suppressor by protein crosslinking. Oncogene 30, 4780-4790. DOI |
12 | Kim, S. Y. (2011) Transglutaminase 2: a new paradigm for NF-kappaB involvement in disease. Adv. Enzymol. Relat. Areas Mol. Biol. 78, 161-195. DOI |
13 | Ku, B. M., Kim, D. S., Kim, K. H., Yoo, B. C., Kim, S. H., Gong, Y. D. and Kim, S. Y. (2013) Transglutaminase 2 inhibition found to induce p53 mediated apoptosis in renal cell carcinoma. FASEB J. 27, 3487-3495. DOI |
14 | Ku, B. M., Kim, S. J., Kim, N., Hong, D., Choi, Y. B., Lee, S. H., Gong, Y. D. and Kim, S. Y. (2014) Transglutaminase 2 inhibitor abrogates renal cell carcinoma in xenograft models. J. Cancer Res. Clin. Oncol. 140, 757-767. DOI |
15 | Tasdemir, E., Maiuri, M. C., Galluzzi, L., Vitale, I., Djavaheri-Mergny, M., D'Amelio, M., Criollo, A., Morselli, E., Zhu, C., Harper, F., Nannmark, U., Samara, C., Pinton, P., Vicencio, J. M., Carnuccio, R., Moll, U. M., Madeo, F., Paterlini-Brechot, P., Rizzuto, R., Szabadkai, G., Pierron, G., Blomgren, K., Tavernarakis, N., Codogno, P., Cecconi, F. and Kroemer, G. (2008b) Regulation of autophagy by cytoplasmic p53. Nat. Cell Biol. 10, 676-687. DOI |
16 | Lee, J., Kim, Y. S., Choi, D. H., Bang, M. S., Han, T. R., Joh, T. H. and Kim, S. Y. (2004) Transglutaminase 2 induces nuclear factor-kappaB activation via a novel pathway in BV-2 microglia. J. Biol. Chem. 279, 53725-53735. DOI |
17 | Munafo, D. B. and Colombo, M. I. (2001) A novel assay to study autophagy: regulation of autophagosome vacuole size by amino acid deprivation. J Cell Sci. 114, 3619-3629. DOI |
18 | Rabinowitz, J. D. and White, E. (2010) Autophagy and metabolism. Science 330, 1344-1348. DOI |
19 | Scherz-Shouval, R., Weidberg, H., Gonen, C., Wilder, S., Elazar, Z. and Oren, M. (2010) p53-dependent regulation of autophagy protein LC3 supports cancer cell survival under prolonged starvation. Proc. Natl. Acad. Sci. U.S.A. 107, 18511-18516. DOI |
20 | Tasdemir, E., Chiara Maiuri, M., Morselli, E., Criollo, A., D'Amelio, M., Djavaheri-Mergny, M., Cecconi, F., Tavernarakis, N. and Kroemer, G. (2008a) A dual role of p53 in the control of autophagy. Autophagy 4, 810-814. DOI |
21 | Verma, A., Guha, S., Wang, H., Fok, J. Y., Koul, D., Abbruzzese, J. and Mehta, K. (2008) Tissue transglutaminase regulates focal adhesion kinase/AKT activation by modulating PTEN expression in pancreatic cancer cells. Clin. Cancer Res. 14, 1997-2005. DOI |
22 | White, E. (2012) Deconvoluting the context-dependent role for autophagy in cancer. Nat. Rev. Cancer 12, 401-410. DOI |